Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Rize Oncology Inc (EM) RZONF

Healthcare Biotechnology
Rize Oncology Inc., a biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications. It develops STS-201, a small-molecule drug for the treatment of soft tissue sarcoma. The company was formerly known as GeneTether Therapeutics Inc. and changed its name to Rize Oncology Inc. in January 2025. Rize Oncology Inc. was incorporated in 2018 and is... see more

Current News (EXPM:RZONF)

Rize Oncology Announces Warrant Incentive Program

TheNewsWire April 13, 2026

Rize Oncology Announces Appointment Of Interim CEO

TheNewsWire October 16, 2025

Rize Oncology Announces Appointment Of Interim Ceo

TheNewsWire July 10, 2025

CSE Bulletin: Delist - Rize Oncology Inc. (RIZE)

Newsfile May 20, 2025

Corporate Update: Rize Oncology Announces Expansion into Australia, Manufacturing Partnership for STS-201, and Approval for CSE Delisting

TheNewsWire May 16, 2025

Rize Oncology Inc. Announces Intention to Seek Shareholder Approval for Voluntary Delisting from the Canadian Securities Exchange

TheNewsWire April 22, 2025

CSE Bulletin: Name and Symbol Change - GeneTether Therapeutics Inc. (GTTX)

Newsfile January 10, 2025

GeneTether Therapeutics Announces Name Change to Rize Oncology, Reflecting New Focus on Oncology

TheNewsWire January 9, 2025

GeneTether Therapeutics Announces Closing of Licensing Agreement for STS-201 and $500,000 Non-Brokered Private Placement

TheNewsWire January 6, 2025
View More News ››

Opinion & Analysis (EXPM:RZONF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:RZONF)

RE:RE:RE:Q4/year-end coming soon

1. No longer on CDN exchange. 2. But I remain confident that management has a plan to get things going (soon) ... possibly down-under!
CashFlowReality - July 2, 2025

RE:RE:Q4/year-end coming soon

sedar has been updated . 
CashFlowReality - April 16, 2025

RE:Q4/year-end coming soon

quarterly coming very soon... should be awesome!
CashFlowReality - March 14, 2025

Q4/year-end coming soon

Should be great!
CashFlowReality - January 23, 2025

RE:300% share price increase

look at 16th October news release
CashFlowReality - November 21, 2024

300% share price increase

Anyone know what's driving the share price right now? 
ElBorto - November 20, 2024
View more Bullboard ››

TomaGold Corp.

TomaGold Corp.

TomaGold Corporation, together with its subsidiaries, engages in the acquisition, exploration, assessment, and development of ...
View More »

Podcasts